BATON ROUGE, La. (July 28, 2022)—Second quarter earnings for Amedisys are down $6.3 million compared to 2021, the company said in a press release this week. The report covered the three-month period ending June 30.
The company’s adjusted earnings before tax, depreciation and amortization (EBITDA) were also down nearly 11%, from $83.8 million to $74.4 million.
